Crotedumab

From WikiMD's Food, Medicine & Wellness Encyclopedia

Crotedumab (REGN1193) (INN) is a humanized monoclonal antibody designed for the treatment of diabetes.[1][2]

This drug was developed by Regeneron Pharmaceuticals.

References[edit | edit source]

  1. ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Crotedumab, American Medical Association.
  2. ↑

Portions of content adapted from Wikipedia's article on Crotedumab which is released under the CC BY-SA 3.0.

Stub icon

This monoclonal antibody–related article is a stub. You can help WikiMD by expanding it.

‎

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Retrieved from "https://wikimd.com/w/index.php?title=Crotedumab&oldid=5535224"

Contributors: Prab R. Tumpati, MD